Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
RA Capital Management

RA Capital Management

● Actively deploying Boston, United States · Founded 2004

Investment thesis

RA Capital Management is an evidence-based healthcare and planetary health investor and company builder, active from seed through venture, growth and crossover rounds and continuing to fund companies through their IPOs. Founded in 2004, it manages over $14.4 billion, grounds decisions in its TechAtlas research engine and originates new companies through its Raven incubator.

Past investments

Company Round Date Round size
Artios Cambridge, United Kingdom Series D+ Nov 2025 €105.8M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.